Xilio Therapeutics logo

Xilio Therapeutics share price today

(XLO)

Xilio Therapeutics share price is $1 & ₹85.81 as on 7 Jan 2025, 2.30 'hrs' IST

$1

-0.1

(-9.09%)

Market is closed - opens 8 PM, 07 Jan 2025

View live Xilio Therapeutics share price in Dollar and Rupees. Guide to invest in Xilio Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Xilio Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Xilio Therapeutics share price movements

  • Today's Low: $0.96
    Today's High: $1.10

    Day's Volatility :12.73%

  • 52 Weeks Low: $0.50
    52 Weeks High: $1.93

    52 Weeks Volatility :74.09%

Xilio Therapeutics Returns

PeriodXilio Therapeutics, Inc.Sector (Health Care)Index (Russel 2000)
3 Months
46.24%
-8.4%
0.0%
6 Months
13.39%
-3.8%
0.0%
1 Year
27.91%
-0.1%
0.0%
3 Years
-92.57%
2.9%
-19.8%

Xilio Therapeutics Key Statistics

in dollars & INR

Previous Close
$1.1
Open
$1.1
Today's High
$1.1
Today's Low
$0.96
Market Capitalization
$43.7M
Today's Volume
$548.1K
52 Week High
$1.93
52 Week Low
$0.5001
Revenue TTM
$4.6M
EBITDA
$-62.4M
Earnings Per Share (EPS)
$-1.55
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-170.96%

How to invest in Xilio Therapeutics from India?

It is very easy for Indian residents to invest directly in Xilio Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Xilio Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Xilio Therapeutics or XLO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Xilio Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Xilio Therapeutics shares which would translate to 0.858 fractional shares of Xilio Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Xilio Therapeutics, in just a few clicks!

Returns in Xilio Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Xilio Therapeutics investment value today

Current value as on today

₹1,19,502

Returns

₹19,502

(+19.5%)

Returns from Xilio Therapeutics Stock

₹16,279 (+16.28%)

Dollar Returns

₹3,223 (+3.22%)

Indian investors sentiment towards Xilio Therapeutics

131%

Period: Oct 8, 2024 to Jan 6, 2025. Change in 30 Days versus previous period

Search volume for Xilio Therapeutics on INDmoney from India has grown in the last 30 days as on Jan 7, 2025. 131% more investors are searching Xilio Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Xilio Therapeutics

  • Bain Capital Life Sciences Investors, LLC

    10.39%

  • Rock Springs Capital Management LP

    6.83%

  • Morgan Stanley - Brokerage Accounts

    3.46%

  • RiverVest Venture Management LLC

    3.28%

  • FMR Inc

    3.18%

  • Vanguard Group Inc

    2.05%

Analyst Recommendation on Xilio Therapeutics

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Xilio Therapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
7
7
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Xilio Therapeutics

What analysts predicted

Upside of 350.0%

Current:

$1.00

Target:

$4.50

Insights on Xilio Therapeutics

  • Price Movement

    In the last 7 days, XLO stock has moved up by 13.4%
  • XLO vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 55.2% return, outperforming this stock by 147.5%

Xilio Therapeutics Technicals Summary

Sell

Neutral

Buy

Xilio Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Xilio Therapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Xilio Therapeutics, Inc.
1.85%
13.39%
27.91%
-92.57%
-93.12%
Regeneron Pharmaceuticals, Inc.
-8.86%
-31.87%
-20.46%
15.59%
87.28%
Biontech Se
-4.16%
43.82%
3.49%
-49.66%
167.6%
Alnylam Pharmaceuticals, Inc.
-8.45%
-8.03%
19.03%
56.02%
98.44%
Vertex Pharmaceuticals Incorporated
-14.11%
-16.23%
-2.87%
81.78%
76.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Xilio Therapeutics, Inc.
NA
NA
NA
-1.21
-1.71
-0.53
NA
0.48
Regeneron Pharmaceuticals, Inc.
17.61
17.61
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Xilio Therapeutics, Inc.
Buy
$43.7M
-93.12%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.3B
87.28%
17.61
33.61%
Biontech Se
Buy
$27.3B
167.6%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$30.4B
98.44%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$103.7B
76.8%
32.84
-4.51%

About Xilio Therapeutics

xilio is a waltham, massachusetts-based biopharmaceutical company focused on defeating cancer. the company’s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, xilio, derived from the latin term, ex nihilo, meaning creation or big-bang. xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer. to learn more, please visit www.xiliotx.com.
Organization
Xilio Therapeutics
Employees
73
CEO
Dr. Rene Russo BCPS, Pharm.D.
Industry
Services

Management People of Xilio Therapeutics

NameTitle
Dr. Rene Russo BCPS, Pharm.D.
President, CEO & Director
Mr. Christopher Frankenfield
Chief Operating Officer
Dr. Katarina Luptakova M.D.
Chief Medical Officer
Mr. Kevin M. Brennan
Senior VP of Finance & Accounting
Dr. Uli Bialucha Ph.D.
Chief Scientific Officer
Ms. Caroline Hensley
Chief Legal Officer
Dr. Scott Coleman Ph.D.
Chief Development Officer

Important FAQs about investing in Xilio Therapeutics from India :

What is Xilio Therapeutics share price today?

Xilio Therapeutics share price today stands at $1.00, Open: $1.10 ; Previous Close: $1.10 ; High: $1.10 ; Low: $0.96 ; 52 Week High: $1.93 ; 52 Week Low: $0.50. The stock opens at $1.10, after a previous close of $1.10. The stock reached a daily high of $1.10 and a low of $0.96, with a 52-week high of $1.93 and a 52-week low of $0.50.

Can Indians buy Xilio Therapeutics shares?

Yes, Indians can invest in the Xilio Therapeutics (XLO) from India.

With INDmoney, you can buy Xilio Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Xilio Therapeutics at zero transaction cost.

How can I buy Xilio Therapeutics shares from India?

It is very easy to buy Xilio Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Xilio Therapeutics be purchased?

Yes, you can buy fractional shares of Xilio Therapeutics with INDmoney app.

What are the documents required to start investing in Xilio Therapeutics stocks?

To start investing in Xilio Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Xilio Therapeutics

Today’s highest price of Xilio Therapeutics (XLO) is $1.10.

Today’s lowest price of Xilio Therapeutics (XLO) is $0.96.

What is today's market capitalisation of Xilio Therapeutics

Today's market capitalisation of Xilio Therapeutics XLO is 43.7M

What is the 52 Week High and Low Range of Xilio Therapeutics

  • 52 Week High

    $1.93

  • 52 Week Low

    $0.50

What are the historical returns of Xilio Therapeutics?

  • 1 Month Returns

    1.85%

  • 3 Months Returns

    13.39%

  • 1 Year Returns

    27.91%

  • 5 Years Returns

    -93.12%

Who is the Chief Executive Officer (CEO) of Xilio Therapeutics

Dr. Rene Russo BCPS, Pharm.D. is the current Chief Executive Officer (CEO) of Xilio Therapeutics.